These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1381 related articles for article (PubMed ID: 24705249)
1. Circulating exosomal microRNAs as biomarkers of colon cancer. Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249 [TBL] [Abstract][Full Text] [Related]
2. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer. Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555 [TBL] [Abstract][Full Text] [Related]
3. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer. Liu X; Chu KM J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554 [TBL] [Abstract][Full Text] [Related]
4. Four circulating exosomal miRNAs as novel potential biomarkers for the early diagnosis of human colorectal cancer. Shi Y; Zhuang Y; Zhang J; Chen M; Wu S Tissue Cell; 2021 Jun; 70():101499. PubMed ID: 33550035 [TBL] [Abstract][Full Text] [Related]
5. Serum exosomal miR-377-3p and miR-381-3p as diagnostic biomarkers in colorectal cancer. Wang L; Song X; Yu M; Niu L; Zhao Y; Tang Y; Zheng B; Song X; Xie L Future Oncol; 2022 Mar; 18(7):793-805. PubMed ID: 34854318 [No Abstract] [Full Text] [Related]
6. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer. Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma. Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer. Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108 [TBL] [Abstract][Full Text] [Related]
9. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Matsumura T; Sugimachi K; Iinuma H; Takahashi Y; Kurashige J; Sawada G; Ueda M; Uchi R; Ueo H; Takano Y; Shinden Y; Eguchi H; Yamamoto H; Doki Y; Mori M; Ochiya T; Mimori K Br J Cancer; 2015 Jul; 113(2):275-81. PubMed ID: 26057451 [TBL] [Abstract][Full Text] [Related]
10. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: A pilot study. Kim JE; Eom JS; Kim WY; Jo EJ; Mok J; Lee K; Kim KU; Park HK; Lee MK; Kim MH Thorac Cancer; 2018 Aug; 9(8):911-915. PubMed ID: 29806739 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918 [No Abstract] [Full Text] [Related]
14. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer. Zhang N; Zhang PP; Huang JJ; Wang ZY; Zhang ZH; Yuan JZ; Ma EM; Liu X; Bai J Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967 [TBL] [Abstract][Full Text] [Related]
15. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients. Zhang Y; Zhang Y; Yin Y; Li S Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974 [TBL] [Abstract][Full Text] [Related]
16. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
17. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer. Yan S; Han B; Gao S; Wang X; Wang Z; Wang F; Zhang J; Xu D; Sun B Oncotarget; 2017 Sep; 8(36):60149-60158. PubMed ID: 28947960 [TBL] [Abstract][Full Text] [Related]
18. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer. Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161 [TBL] [Abstract][Full Text] [Related]
19. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225 [TBL] [Abstract][Full Text] [Related]
20. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]